摘要
In an epidemiologic and case-control study including 30 case patients over a 3.5-year period in a Taiwanese university hospital, only β-lactamase inhibitor use and extended-spectrum cephalosporin use were identified as independent risk factors for nosocomial CMY-2-producing Escherichia coli bloodstream infection, and CMY-2 producers were found more prevalent than extended-spectrum β-lactamase-producing isolates.
原文 | English |
---|---|
頁(從 - 到) | 3329-3332 |
頁數 | 4 |
期刊 | Journal of Clinical Microbiology |
卷 | 42 |
發行號 | 7 |
DOIs | |
出版狀態 | Published - 2004 7月 |
All Science Journal Classification (ASJC) codes
- 微生物學(醫學)